Intravenous (IV) Ibuprofen Market Size and Share

1. WorldIntravenous (IV) IbuprofenMarket Opportunitiesand Forecasts, 2015 –2022

2. IntroductionofIntravenousIbuprofonMarket Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation occurred due to a disease, operative procedures or trauma, and acute illness. The intravenous (IV) route for ibuprofen administration has a faster onset of action as compared to the other routes. IV ibuprofen is preferred for the management of post-operative and acute pain. The demand for ibuprofen has increased due to the side effects of opioid analgesics such as respiratory depression, allergic reactions, sedation, and gastrointestinalevents. The market for IV ibuprofen for pain management is in its nascent stage. The world IV ibuprofen market was valued at $3.6 million in 2015, and is projected to reach $14.2 million by 2022, registering a CAGR of 20% during the forecast period. Advantages associated with IV ibuprofen such as rapid result and targeted drug delivery have resulted in the growth of this market. In 2015, FDA approved IV ibuprofen for pediatric use, due to which the market is expected to register a significant growth during the forecast period. Other factors that affect the market growth significantly include increasing incidence of cancer, cardiovascular ailments, pain, headache, toothache, back pain, arthritis, trauma, and shifting trend towards the use of non-opioids drugs. Factors that would hamper the market growth include side effects associated with IV ibuprofen and lengthy approvalprocess.

3. Introduction Scopeof theReport KeyBenefits KeyAudiences

4. KeyBenefits Introduction toSmart Syringes Market • This report provides an extensive analysis of the current and emerging trends and dynamics in the world IV Ibuprofenmarket. • The world IV Ibuprofen market is analyzed based on countries such as the U.S., Australia, Canada and SouthKorea. • Thestudyevaluatingcompetitivelandscapehasbeentakenintoaccountto • understand the competitive environment across the countriesconsidered. • This report provides detailed quantitative analysis of the current market and estimations from 2015 to 2022, which assists to identify the prevailing opportunities. • ExhaustiveanalysisoftheworldIVIbuprofenmarketbyindicationdescribes • the types of indications that will gain prominence infuture. Syntheticbiologyisanovelareaofresearchthatistheamalgamationofmultipledisciplinessuch as molecular biology, biotechnology, biophysics and genetic engineering among others. There are chiefly two approaches used in synthetic biology namely, top down approach and bottom up approach. Top-down approach involves the re-design and fabrication of existing biological systems for producing synthetic products. Bottom-up approach involves designing and construction of de novo biological systems or devices that do not exist innature. World synthetic biology market was valued at $ 5,245.7 million in 2015, growing at a CAGR of 23% during the forecast period. Assistance from government and private organizations, rising number of synthetic biology research entities and declining cost of DNA sequencing & synthesizing are the major factors driving the market growth. On the contrary, bio-safety & bio-security issues, would hinder the market growth. The issues related to the misuse of synthetic biology or possibilities of accidental release of pathogens into free atmosphere would remain as a key challenge worldwide. However, rising demand for bio-fuels, growing awareness in emerging economies and rising R&D investments for synthetic drugs and vaccines would offer lucrative opportunities in themarket

5. Table ofContents: Introduction Executive Summary Market Overview World Intravenous Ibuprofen market, By Age Group,2015-2022 World Intravenous Ibuprofen Market, By Indication,2015-2022 World Intravenous Ibuprofen Market, By Country,2015-2022 CompanyProfiles Enquiry about report at:https://www.alliedmarketresearch.com/purchase-enquiry/1387

6. World Intravenous Ibuprofen – MarketBy Segments KEY MARKET SEGMENTS MARKET BY INDICATIONS MARKET BY AGEGROUP MARKET BY GEOGRAPHY

7. Intravenous Ibuprofen MarketKey Introduction toSmart Syringes Market Syntheticbiologyisanovelareaofresearchthatistheamalgamationofmultipledisciplinessuch as molecular biology, biotechnology, biophysics and genetic engineering among others. There are chiefly two approaches used in synthetic biology namely, top down approach and bottom up approach. Top-down approach involves the re-design and fabrication of existing biological systems for producing synthetic products. Bottom-up approach involves designing and construction of de novo biological systems or devices that do not exist innature. World synthetic biology market was valued at $ 5,245.7 million in 2015, growing at a CAGR of 23% during the forecast period. Assistance from government and private organizations, rising number of synthetic biology research entities and declining cost of DNA sequencing & synthesizing are the major factors driving the market growth. On the contrary, bio-safety & bio-security issues, would hinder the market growth. The issues related to the misuse of synthetic biology or possibilities of accidental release of pathogens into free atmosphere would remain as a key challenge worldwide. However, rising demand for bio-fuels, growing awareness in emerging economies and rising R&D investments for synthetic drugs and vaccines would offer lucrative opportunities in themarket Pain/Inflammatory ByIndications Fever

8. Intravenous Ibuprofen MarketKey Introduction toSmart Syringes Market Syntheticbiologyisanovelareaofresearchthatistheamalgamationofmultipledisciplinessuch as molecular biology, biotechnology, biophysics and genetic engineering among others. There are chiefly two approaches used in synthetic biology namely, top down approach and bottom up approach. Top-down approach involves the re-design and fabrication of existing biological systems for producing synthetic products. Bottom-up approach involves designing and construction of de novo biological systems or devices that do not exist innature. World synthetic biology market was valued at $ 5,245.7 million in 2015, growing at a CAGR of 23% during the forecast period. Assistance from government and private organizations, rising number of synthetic biology research entities and declining cost of DNA sequencing & synthesizing are the major factors driving the market growth. On the contrary, bio-safety & bio-security issues, would hinder the market growth. The issues related to the misuse of synthetic biology or possibilities of accidental release of pathogens into free atmosphere would remain as a key challenge worldwide. However, rising demand for bio-fuels, growing awareness in emerging economies and rising R&D investments for synthetic drugs and vaccines would offer lucrative opportunities in themarket Pediatrics By AgeGroups Adults

9. CompanyProfiles Cumberland PharmaceuticalsInc. Alveda Pharmaceuticals,Inc. CSL Limited, Sandor Medicaids PvtLtd. PT. Soho IndustriPharmasi Germin MED, GrifolsS.A. Harbin Gloria Pharmaceuticals Co.,Ltd. Al Nabeel InternationalLtd. Laboratorios Valmorca,C.A.

10. ThankYou! For MoreDetails Visit usat https://www.alliedmarketresearch.com/intravenous- ibuprofen-market Follow UsOn